Addressing antimicrobial resistance in cancer care: the critical role of the cancer health workforce

Antimicrobial resistance (AMR) poses a serious threat to cancer care, compromising the effectiveness of essential treatments and increasing the risk of life-threatening infections.

This policy brief by UICC and the UICC-led AMR and Cancer Care Taskforce, with the support of The Trinity Challenge, explores the impact of antimicrobial resistance (AMR) on cancer care, highlighting challenges for cancer health professionals and aims to discuss key areas where cancer health professionals can focus their efforts to contain AMR and enhance cancer care outcomes. Strengthening these efforts is essential to safeguarding patient outcomes and ensuring the future effectiveness of cancer therapies.